Novavax (NVAX) Tops Q2 EPS by 8c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.93 +5.00%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.32), $0.08 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $57 million versus the consensus estimate of $52.06 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
- Trump on ban on diesel exports: I've called for that too
- Goldman Sachs on Viking Therapeutic (VKTX): 'we believe these results look encouraging'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
